Health Canada has given Sensus Healthcare the go-ahead to market its SRT-100 system in that country. The device, tailored for use in hospitals and private physician practices, is designed to treat patients with non-melanoma skin cancer without the need for surgery.
Health Canada approves skin cancer device from Sensus
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||